Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002591316 | SCV002953004 | uncertain significance | not provided | 2024-06-10 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 3881 of the HMCN1 protein (p.Gly3881Ser). This variant is present in population databases (rs779380704, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with HMCN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1920858). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004065748 | SCV003957347 | uncertain significance | not specified | 2023-03-29 | criteria provided, single submitter | clinical testing | The c.11641G>A (p.G3881S) alteration is located in exon 76 (coding exon 76) of the HMCN1 gene. This alteration results from a G to A substitution at nucleotide position 11641, causing the glycine (G) at amino acid position 3881 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome- |
RCV003455545 | SCV004179884 | uncertain significance | Age related macular degeneration 1 | 2023-04-11 | criteria provided, single submitter | clinical testing |